Immunicon Corp. (IMMCQ/IMMCQ.PK) Wrap Up:

Immunicon Corporation engages in the development, manufacture, marketing, and sale of cell-based diagnostic and life science research products and service activities with a focus on cancer. The company develops technologies that identify, count, and characterize a small number of circulating tumor cells (CTC) and other rare cells present in a blood sample of a patient. It offers CellTracks AutoPrep system, an automated clinical laboratory instrument that captures, labels, and concentrates cells of interest from a sample of blood; CellSave preservative tube, a specialty blood collection device that enables to draw blood into an evacuated test tube and preserve the blood samples; and CellTrack...